Diagnostic Pathology: Hepatobiliary and Pancreas 4e delivers a comprehensive reference for both practicing pathologists and pathologists in training. The book's content set provides identification and diagnosis of neoplastic and non-neoplastic diseases of the digestive tract as well as the pancreas and liver. Liver disease often poses a challenge for surgical pathologists due to the common occurrence of overlap among the entities in any given differential diagnosis. For instance, small variances seen in vascular tumors of the liver can be diagnosed as hepatic small vessel neoplasms or anastomosing hemangioma vs. angiosarcoma. Neoplastic lesions of the liver, pancreas, and biliary system may also be difficult to diagnose, especially if infrequently encountered. Diagnostic Pathology: Hepatobiliary and Pancreas provides awareness of the most current components of the WHO Classification on GI, Liver, and Pancreas Tumors. Chapter contents incorporate the most recent clinical, pathological, and molecular knowledge to provides a comprehensive overview of key issues. The 4th edition is designed to help identify and diagnose pathology specimens so all levels of pathologists can build pathology reports which present the most accurate diagnosis possible for patients.

Updates included on new AASLD HCC Guidelines and EASL cholangiocarcinoma guidelines

Details on the increasing/emerging use of molecular means to diagnose cholestatic biliary liver conditions and other liver disease of unknown etiology

Notes terminology changes for NAFLD to the current MASLD (metabolic dysfunction associated steatotic liver disease) which is critical for pathologists to be aware of

Provides clear delineations between challenging diagnosis of vascular liver tumors distinctions between hepatic small vessel neoplasm/anastomosing hemangioma vs. angiosarcoma

Advances in pathology for liver, pancreas and biliary systems are included across the 4th ed in new images, updated text, and the most current literature references

For the 4th edition, the author team adds in advances in diagnostic pathology for liver, pancreas and biliary systems in new images, updated text, and the most current literature reference. This includes

Details on the increasing/emerging use of molecular means to diagnose cholestatic biliary liver conditions and other liver disease of unknown etiology updates included on new AASLD HCC Guidelines and EASL cholangiocarcinoma guidelines

Notes terminology changes for NAFLD to the current MASLD (metabolic dysfunction associated steatotic liver disease) which is critical for pathologists to be aware of

Provides clear delineations between challenging diagnosis of vascular liver tumors distinctions between hepatic small vessel neoplasm/anastomosing hemangioma vs. angiosarcoma

Updates on new AASLD HCC Guidelines and EASL cholangiocarcinoma guidelines

Updates on new AASLD HCC Guidelines and EASL cholangiocarcinoma guidelines

...read more